Aveo Pharma Stock Price, News & Analysis
Company Description
Aveo Pharma (NASDAQ: AVEO) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $521.4M.
AVEO stock has gained 302.1% over the past year.
This page provides a comprehensive overview of AVEO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Aveo Pharma (AVEO) stock. Over the past 12 months, the stock has gained 302.1%. At a market capitalization of $521.4M, AVEO is classified as a small-cap stock with approximately 34.8M shares outstanding.
Latest News
Aveo Pharma has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include management, clinical trial, acquisition, earnings. View all AVEO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AVEO Company Profile & Sector Positioning
Aveo Pharma (AVEO) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.